ELLICOTT CITY, Md. -- The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today announced an expanded relationship with Acurian Inc., a leading, full-service provider of global patient enrollment and retention solutions and a subsidiary of PPD.
Through this intensified relationship, Acurian will initiate a Site Advocacy Group (SAG) focused on global patient recruitment and sponsor both the 2015 SCRS Eagle Award and Site Patient Recruitment Innovation Award (SPRIA). Acurian also will continue as a Global Impact Partner and sponsor of 2015 Good Business Practices and Good Clinical Practices webinars.
"SCRS is pleased to have Acurian's support for a number of important member programs," comments Christine Pierre, SCRS President. "Acurian's commitment to promoting greater site sustainability across the clinical research landscape is directly aligned with SCRS' mission, and will enhance quality and efficiency in the conduct of clinical trials globally."
Todd Albin, Acurian's senior director of site enrollment optimization, said, "Acurian is committed to establishing and enhancing relationships with research sites throughout the world. We recognize SCRS as the leading organization to represent the interests of research sites worldwide, and we are excited about the expansion of our partnership."
As a Site Engagement Partner, Acurian will continue to participate on the SCRS Global Impact Board at an executive level, and work closely with SCRS' Leadership Council to determine strategic initiatives for SCRS.
SCRS is a global trade organization founded in 2012 which represents over 2,300 research sites, including 30,000 research professionals in 39 countries. SCRS' mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites, as well as companies that sponsor or support the work conducted at clinical research sites, will benefit from membership and partnership. Visit MySCRS.org.
Acurian, a subsidiary of PPD, is a leading full-service provider of clinical trial patient enrollment and retention solutions for the life sciences industry. The company increases the enrollment performance of investigator sites worldwide by identifying, contacting, prescreening and referring people who live in the local community but are unknown to a research site. As a result, trial sponsors complete enrollment without incurring the unexpected expense of adding sites or time.
PPD is a leading global contract research organization providing drug discovery, development, lifecycle management and laboratory services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and more than 13,500 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments. For more information, visit www.ppdi.com.